IQVIA Stock Price - IQV

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 146.12 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
IQVIA Holdings Inc IQV NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.28 -0.19% 146.12 146.98 145.02 146.70 146.40 17:59:44
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
15,958 1,609,474 $ 145.82 $ 234,698,939 1,392,486 104.90 - 164.13
Last Trade Time Type Quantity Stock Price Currency
18:29:39 105,782 $ 146.12 USD

IQVIA Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 28.35B 194.04M $ 259.00M 1.23 120.10 183.50M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.76M $ - 0.00% -2.00 5.40%

more financials information »


Loading Messages....

Latest IQV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IQV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week143.74148.94142.69145.501,119,4192.381.66%
1 Month139.90148.94139.90144.861,186,2276.224.45%
3 Months151.10158.25136.28146.621,379,209-4.98-3.3%
6 Months139.64164.13136.28150.451,305,0656.484.64%
1 Year118.60164.13104.90142.251,257,85827.5223.2%
3 Years102.67164.1391.5701126.461,156,66143.4542.32%
5 Years102.67164.1391.5701126.461,156,66143.4542.32%

IQVIA Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The CRO segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.